Recent Updates on Nanomedicine Based Products: Current Scenario and Future Opportunities

Author(s): Ajmer Singh Grewal, Viney Lather*, Neelam Sharma, Sukhbir Singh, R.S. Narang, Jasjeet Kaur Narang, Deepti Pandita.

Journal Name: Applied Clinical Research, Clinical Trials and Regulatory Affairs

Volume 5 , Issue 2 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Nanomedicine, defined as the application of nanotechnology for the prevention, cure and diagnosis of diseases, has emerged as one of the most exciting tools in the medical field for direct benefit to human health. Nanomedicine aims to engineer the materials at nanoscale to develop new drugs, delivery systems in a way to mimic or understand the cellular processes at molecular level for therapeutics of diseases. Based on their applications, nanomedicines include nano drug delivery systems, nano-diagnostics, nano-theranostics, and nano-medical implants.

Objectives: The current manuscript will provide a global scenario about different nanomedicines and their applications, the overall market, and the ongoing developments in their regulation by different regulatory bodies.

Discussion: The different properties displayed by materials at nano-scale in terms of size, chemical reactivity, solubility, mobility, magnetic and optical properties open the ways for their utilization in the field of medicine. The Food and Drug Administration (FDA) has approved products using nanotechnology under different product categories. The last two decades have seen a tremendous growth in the development of nanomedicine-based products in global regulatory markets particularly in the area of drug delivery systems and diagnosis.

Keywords: Nano-drug delivery systems, nanomedicine, nanotechnology, nanotheranostics, quality and safety, regulatory aspects.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 5
ISSUE: 2
Year: 2018
Page: [132 - 144]
Pages: 13
DOI: 10.2174/2213476X05666180611115135

Article Metrics

PDF: 13
HTML: 1
EPUB: 1
PRC: 2